Folic acid and RAAS blockers in ischemia/reperfusion-induced hepatic injury: A current mechanistic concept for understanding the incidence, significance & outcome
- 28 June 2020
- journal article
- review article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 327, 109187
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Effect of Rosiglitazone, a PPAR‐γ Ligand on Haloperidol‐Induced CatalepsyCNS Neuroscience & Therapeutics, 2013
- Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes MellitusCardiorenal Medicine, 2011
- Effect of enalapril on plasma homocysteine levels in patients with essential hypertensionJournal of Zhejiang University-SCIENCE B, 2010
- Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for TherapyThe American Journal of Cardiology, 2010
- The Treatment of HyperhomocysteinemiaAnnual Review of Medicine, 2009
- Glutathione Peroxidase-1 and Homocysteine for Cardiovascular Risk PredictionJACC, 2005
- Angiotensin IV in the central nervous systemCell and tissue research, 2003
- Physiological and Pathophysiological Functions of the AT2Subtype Receptor of Angiotensin IIHypertension, 2001
- Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentrationAtherosclerosis, 1995
- Increased Plasma Inactive Renin in Diabetes MellitusNew England Journal of Medicine, 1985